Lv31
378 积分 2024-10-14 加入
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
5小时前
待确认
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
14天前
已完结
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
20天前
已完结
Study design for a three-arm equivalence clinical trial with binomially distributed outcomes
27天前
已完结
Asciminib in newly diagnosed chronic myeloid leukemia
1个月前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
1个月前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
1个月前
已完结
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
1个月前
已完结
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes
1个月前
已完结
Sequence-based protein binding site prediction using a multi-channel graph neural network
2个月前
已完结
皖公网安备34019202002308
